Nalaganje...
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...
Shranjeno v:
| izdano v: | Mod Rheumatol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4732415/ https://ncbi.nlm.nih.gov/pubmed/26054418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1060665 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|